Poolbeg Pharma PLC
LSE:POLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Poolbeg Pharma PLC
LSE:POLB
|
UK |
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
CN |
|
J
|
JBS SA
XBER:YJ3A
|
BR |
|
A
|
APx Acquisition I Corp
NASDAQ:APXI
|
MX |
|
Seadrill Ltd
OSE:SDRL
|
BM |
Balance Sheet
Balance Sheet Decomposition
Poolbeg Pharma PLC
Poolbeg Pharma PLC
Balance Sheet
Poolbeg Pharma PLC
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
21
|
16
|
12
|
8
|
|
| Cash Equivalents |
21
|
16
|
12
|
8
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
|
| Total Current Assets |
21
|
17
|
13
|
9
|
|
| Intangible Assets |
2
|
2
|
2
|
2
|
|
| Total Assets |
23
N/A
|
19
-16%
|
15
-20%
|
10
-34%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+121%
|
1
+2%
|
1
-1%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
5
|
9
|
14
|
|
| Additional Paid In Capital |
23
|
23
|
23
|
23
|
|
| Total Equity |
23
N/A
|
18
-19%
|
14
-21%
|
9
-36%
|
|
| Total Liabilities & Equity |
23
N/A
|
19
-16%
|
15
-20%
|
10
-34%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
500
|
500
|
500
|
500
|
|